Global Next-Generation Oncology Devices Market Growth 2025-2031--LP INFORMATION, INC.

Global Next-Generation Oncology Devices Market Growth 2025-2031

Product Code: 1375443

Industry: Machinery & Equipment

Published: Feb 12,2025

Pages: 79

Delivery Time: 2-3 business days

Global Next-Generation Oncology Devices Market Growth 2025-2031

Product Code: 1375443

Industry: Machinery & Equipment

Published: Feb 12,2025

Pages: 79

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Next-Generation Oncology Devices market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

United States market for Next-Generation Oncology Devices is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Next-Generation Oncology Devices is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Next-Generation Oncology Devices is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Next-Generation Oncology Devices players cover Elekta, Accuray, IBA, Philips, GE, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Next-Generation Oncology Devices Industry Forecast” looks at past sales and reviews total world Next-Generation Oncology Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Next-Generation Oncology Devices sales for 2025 through 2031. With Next-Generation Oncology Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next-Generation Oncology Devices industry.

This Insight Report provides a comprehensive analysis of the global Next-Generation Oncology Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Next-Generation Oncology Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Next-Generation Oncology Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next-Generation Oncology Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next-Generation Oncology Devices.

This report presents a comprehensive overview, market shares, and growth opportunities of Next-Generation Oncology Devices market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Radiation Therapy Equipment

    Endoscopic Equipment

Segmentation by Application:

    Breast Cancer

    Lung Cancer

    Oral Cancer

    Stomach Cancer

    Cervical Cancer

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Elekta

    Accuray

IBA

    Philips

GE

Key Questions Addressed in this Report

What is the 10-year outlook for the global Next-Generation Oncology Devices market?

What factors are driving Next-Generation Oncology Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Next-Generation Oncology Devices market opportunities vary by end market size?

How does Next-Generation Oncology Devices break out by Type, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Next-Generation Oncology Devices Annual Sales 2020-2031
        2.1.2 World Current & Future Analysis for Next-Generation Oncology Devices by Geographic Region, 2020, 2024 & 2031
        2.1.3 World Current & Future Analysis for Next-Generation Oncology Devices by Country/Region, 2020, 2024 & 2031
    2.2 Next-Generation Oncology Devices Segment by Type
        2.2.1 Radiation Therapy Equipment
        2.2.2 Endoscopic Equipment
    2.3 Next-Generation Oncology Devices Sales by Type
        2.3.1 Global Next-Generation Oncology Devices Sales Market Share by Type (2020-2025)
        2.3.2 Global Next-Generation Oncology Devices Revenue and Market Share by Type (2020-2025)
        2.3.3 Global Next-Generation Oncology Devices Sale Price by Type (2020-2025)
    2.4 Next-Generation Oncology Devices Segment by Application
        2.4.1 Breast Cancer
        2.4.2 Lung Cancer
        2.4.3 Oral Cancer
        2.4.4 Stomach Cancer
        2.4.5 Cervical Cancer
    2.5 Next-Generation Oncology Devices Sales by Application
        2.5.1 Global Next-Generation Oncology Devices Sale Market Share by Application (2020-2025)
        2.5.2 Global Next-Generation Oncology Devices Revenue and Market Share by Application (2020-2025)
        2.5.3 Global Next-Generation Oncology Devices Sale Price by Application (2020-2025)

3 Global by Company
    3.1 Global Next-Generation Oncology Devices Breakdown Data by Company
        3.1.1 Global Next-Generation Oncology Devices Annual Sales by Company (2020-2025)
        3.1.2 Global Next-Generation Oncology Devices Sales Market Share by Company (2020-2025)
    3.2 Global Next-Generation Oncology Devices Annual Revenue by Company (2020-2025)
        3.2.1 Global Next-Generation Oncology Devices Revenue by Company (2020-2025)
        3.2.2 Global Next-Generation Oncology Devices Revenue Market Share by Company (2020-2025)
    3.3 Global Next-Generation Oncology Devices Sale Price by Company
    3.4 Key Manufacturers Next-Generation Oncology Devices Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Next-Generation Oncology Devices Product Location Distribution
        3.4.2 Players Next-Generation Oncology Devices Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Next-Generation Oncology Devices by Geographic Region
    4.1 World Historic Next-Generation Oncology Devices Market Size by Geographic Region (2020-2025)
        4.1.1 Global Next-Generation Oncology Devices Annual Sales by Geographic Region (2020-2025)
        4.1.2 Global Next-Generation Oncology Devices Annual Revenue by Geographic Region (2020-2025)
    4.2 World Historic Next-Generation Oncology Devices Market Size by Country/Region (2020-2025)
        4.2.1 Global Next-Generation Oncology Devices Annual Sales by Country/Region (2020-2025)
        4.2.2 Global Next-Generation Oncology Devices Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Next-Generation Oncology Devices Sales Growth
    4.4 APAC Next-Generation Oncology Devices Sales Growth
    4.5 Europe Next-Generation Oncology Devices Sales Growth
    4.6 Middle East & Africa Next-Generation Oncology Devices Sales Growth

5 Americas
    5.1 Americas Next-Generation Oncology Devices Sales by Country
        5.1.1 Americas Next-Generation Oncology Devices Sales by Country (2020-2025)
        5.1.2 Americas Next-Generation Oncology Devices Revenue by Country (2020-2025)
    5.2 Americas Next-Generation Oncology Devices Sales by Type (2020-2025)
    5.3 Americas Next-Generation Oncology Devices Sales by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Next-Generation Oncology Devices Sales by Region
        6.1.1 APAC Next-Generation Oncology Devices Sales by Region (2020-2025)
        6.1.2 APAC Next-Generation Oncology Devices Revenue by Region (2020-2025)
    6.2 APAC Next-Generation Oncology Devices Sales by Type (2020-2025)
    6.3 APAC Next-Generation Oncology Devices Sales by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Next-Generation Oncology Devices by Country
        7.1.1 Europe Next-Generation Oncology Devices Sales by Country (2020-2025)
        7.1.2 Europe Next-Generation Oncology Devices Revenue by Country (2020-2025)
    7.2 Europe Next-Generation Oncology Devices Sales by Type (2020-2025)
    7.3 Europe Next-Generation Oncology Devices Sales by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Next-Generation Oncology Devices by Country
        8.1.1 Middle East & Africa Next-Generation Oncology Devices Sales by Country (2020-2025)
        8.1.2 Middle East & Africa Next-Generation Oncology Devices Revenue by Country (2020-2025)
    8.2 Middle East & Africa Next-Generation Oncology Devices Sales by Type (2020-2025)
    8.3 Middle East & Africa Next-Generation Oncology Devices Sales by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Next-Generation Oncology Devices
    10.3 Manufacturing Process Analysis of Next-Generation Oncology Devices
    10.4 Industry Chain Structure of Next-Generation Oncology Devices

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Next-Generation Oncology Devices Distributors
    11.3 Next-Generation Oncology Devices Customer

12 World Forecast Review for Next-Generation Oncology Devices by Geographic Region
    12.1 Global Next-Generation Oncology Devices Market Size Forecast by Region
        12.1.1 Global Next-Generation Oncology Devices Forecast by Region (2026-2031)
        12.1.2 Global Next-Generation Oncology Devices Annual Revenue Forecast by Region (2026-2031)
    12.2 Americas Forecast by Country (2026-2031)
    12.3 APAC Forecast by Region (2026-2031)
    12.4 Europe Forecast by Country (2026-2031)
    12.5 Middle East & Africa Forecast by Country (2026-2031)
    12.6 Global Next-Generation Oncology Devices Forecast by Type (2026-2031)
    12.7 Global Next-Generation Oncology Devices Forecast by Application (2026-2031)

13 Key Players Analysis
    13.1 Elekta
        13.1.1 Elekta Company Information
        13.1.2 Elekta Next-Generation Oncology Devices Product Portfolios and Specifications
        13.1.3 Elekta Next-Generation Oncology Devices Sales, Revenue, Price and Gross Margin (2020-2025)
        13.1.4 Elekta Main Business Overview
        13.1.5 Elekta Latest Developments
    13.2 Accuray
        13.2.1 Accuray Company Information
        13.2.2 Accuray Next-Generation Oncology Devices Product Portfolios and Specifications
        13.2.3 Accuray Next-Generation Oncology Devices Sales, Revenue, Price and Gross Margin (2020-2025)
        13.2.4 Accuray Main Business Overview
        13.2.5 Accuray Latest Developments
    13.3 IBA
        13.3.1 IBA Company Information
        13.3.2 IBA Next-Generation Oncology Devices Product Portfolios and Specifications
        13.3.3 IBA Next-Generation Oncology Devices Sales, Revenue, Price and Gross Margin (2020-2025)
        13.3.4 IBA Main Business Overview
        13.3.5 IBA Latest Developments
    13.4 Philips
        13.4.1 Philips Company Information
        13.4.2 Philips Next-Generation Oncology Devices Product Portfolios and Specifications
        13.4.3 Philips Next-Generation Oncology Devices Sales, Revenue, Price and Gross Margin (2020-2025)
        13.4.4 Philips Main Business Overview
        13.4.5 Philips Latest Developments
    13.5 GE
        13.5.1 GE Company Information
        13.5.2 GE Next-Generation Oncology Devices Product Portfolios and Specifications
        13.5.3 GE Next-Generation Oncology Devices Sales, Revenue, Price and Gross Margin (2020-2025)
        13.5.4 GE Main Business Overview
        13.5.5 GE Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Next-Generation Oncology Devices Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Table 2. Next-Generation Oncology Devices Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Radiation Therapy Equipment
 Table 4. Major Players of Endoscopic Equipment
 Table 5. Global Next-Generation Oncology Devices Sales by Type (2020-2025) & (K Units)
 Table 6. Global Next-Generation Oncology Devices Sales Market Share by Type (2020-2025)
 Table 7. Global Next-Generation Oncology Devices Revenue by Type (2020-2025) & ($ million)
 Table 8. Global Next-Generation Oncology Devices Revenue Market Share by Type (2020-2025)
 Table 9. Global Next-Generation Oncology Devices Sale Price by Type (2020-2025) & (US$/Unit)
 Table 10. Global Next-Generation Oncology Devices Sale by Application (2020-2025) & (K Units)
 Table 11. Global Next-Generation Oncology Devices Sale Market Share by Application (2020-2025)
 Table 12. Global Next-Generation Oncology Devices Revenue by Application (2020-2025) & ($ million)
 Table 13. Global Next-Generation Oncology Devices Revenue Market Share by Application (2020-2025)
 Table 14. Global Next-Generation Oncology Devices Sale Price by Application (2020-2025) & (US$/Unit)
 Table 15. Global Next-Generation Oncology Devices Sales by Company (2020-2025) & (K Units)
 Table 16. Global Next-Generation Oncology Devices Sales Market Share by Company (2020-2025)
 Table 17. Global Next-Generation Oncology Devices Revenue by Company (2020-2025) & ($ millions)
 Table 18. Global Next-Generation Oncology Devices Revenue Market Share by Company (2020-2025)
 Table 19. Global Next-Generation Oncology Devices Sale Price by Company (2020-2025) & (US$/Unit)
 Table 20. Key Manufacturers Next-Generation Oncology Devices Producing Area Distribution and Sales Area
 Table 21. Players Next-Generation Oncology Devices Products Offered
 Table 22. Next-Generation Oncology Devices Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 23. New Products and Potential Entrants
 Table 24. Market M&A Activity & Strategy
 Table 25. Global Next-Generation Oncology Devices Sales by Geographic Region (2020-2025) & (K Units)
 Table 26. Global Next-Generation Oncology Devices Sales Market Share Geographic Region (2020-2025)
 Table 27. Global Next-Generation Oncology Devices Revenue by Geographic Region (2020-2025) & ($ millions)
 Table 28. Global Next-Generation Oncology Devices Revenue Market Share by Geographic Region (2020-2025)
 Table 29. Global Next-Generation Oncology Devices Sales by Country/Region (2020-2025) & (K Units)
 Table 30. Global Next-Generation Oncology Devices Sales Market Share by Country/Region (2020-2025)
 Table 31. Global Next-Generation Oncology Devices Revenue by Country/Region (2020-2025) & ($ millions)
 Table 32. Global Next-Generation Oncology Devices Revenue Market Share by Country/Region (2020-2025)
 Table 33. Americas Next-Generation Oncology Devices Sales by Country (2020-2025) & (K Units)
 Table 34. Americas Next-Generation Oncology Devices Sales Market Share by Country (2020-2025)
 Table 35. Americas Next-Generation Oncology Devices Revenue by Country (2020-2025) & ($ millions)
 Table 36. Americas Next-Generation Oncology Devices Sales by Type (2020-2025) & (K Units)
 Table 37. Americas Next-Generation Oncology Devices Sales by Application (2020-2025) & (K Units)
 Table 38. APAC Next-Generation Oncology Devices Sales by Region (2020-2025) & (K Units)
 Table 39. APAC Next-Generation Oncology Devices Sales Market Share by Region (2020-2025)
 Table 40. APAC Next-Generation Oncology Devices Revenue by Region (2020-2025) & ($ millions)
 Table 41. APAC Next-Generation Oncology Devices Sales by Type (2020-2025) & (K Units)
 Table 42. APAC Next-Generation Oncology Devices Sales by Application (2020-2025) & (K Units)
 Table 43. Europe Next-Generation Oncology Devices Sales by Country (2020-2025) & (K Units)
 Table 44. Europe Next-Generation Oncology Devices Revenue by Country (2020-2025) & ($ millions)
 Table 45. Europe Next-Generation Oncology Devices Sales by Type (2020-2025) & (K Units)
 Table 46. Europe Next-Generation Oncology Devices Sales by Application (2020-2025) & (K Units)
 Table 47. Middle East & Africa Next-Generation Oncology Devices Sales by Country (2020-2025) & (K Units)
 Table 48. Middle East & Africa Next-Generation Oncology Devices Revenue Market Share by Country (2020-2025)
 Table 49. Middle East & Africa Next-Generation Oncology Devices Sales by Type (2020-2025) & (K Units)
 Table 50. Middle East & Africa Next-Generation Oncology Devices Sales by Application (2020-2025) & (K Units)
 Table 51. Key Market Drivers & Growth Opportunities of Next-Generation Oncology Devices
 Table 52. Key Market Challenges & Risks of Next-Generation Oncology Devices
 Table 53. Key Industry Trends of Next-Generation Oncology Devices
 Table 54. Next-Generation Oncology Devices Raw Material
 Table 55. Key Suppliers of Raw Materials
 Table 56. Next-Generation Oncology Devices Distributors List
 Table 57. Next-Generation Oncology Devices Customer List
 Table 58. Global Next-Generation Oncology Devices Sales Forecast by Region (2026-2031) & (K Units)
 Table 59. Global Next-Generation Oncology Devices Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 60. Americas Next-Generation Oncology Devices Sales Forecast by Country (2026-2031) & (K Units)
 Table 61. Americas Next-Generation Oncology Devices Annual Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 62. APAC Next-Generation Oncology Devices Sales Forecast by Region (2026-2031) & (K Units)
 Table 63. APAC Next-Generation Oncology Devices Annual Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 64. Europe Next-Generation Oncology Devices Sales Forecast by Country (2026-2031) & (K Units)
 Table 65. Europe Next-Generation Oncology Devices Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 66. Middle East & Africa Next-Generation Oncology Devices Sales Forecast by Country (2026-2031) & (K Units)
 Table 67. Middle East & Africa Next-Generation Oncology Devices Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 68. Global Next-Generation Oncology Devices Sales Forecast by Type (2026-2031) & (K Units)
 Table 69. Global Next-Generation Oncology Devices Revenue Forecast by Type (2026-2031) & ($ millions)
 Table 70. Global Next-Generation Oncology Devices Sales Forecast by Application (2026-2031) & (K Units)
 Table 71. Global Next-Generation Oncology Devices Revenue Forecast by Application (2026-2031) & ($ millions)
 Table 72. Elekta Basic Information, Next-Generation Oncology Devices Manufacturing Base, Sales Area and Its Competitors
 Table 73. Elekta Next-Generation Oncology Devices Product Portfolios and Specifications
 Table 74. Elekta Next-Generation Oncology Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 75. Elekta Main Business
 Table 76. Elekta Latest Developments
 Table 77. Accuray Basic Information, Next-Generation Oncology Devices Manufacturing Base, Sales Area and Its Competitors
 Table 78. Accuray Next-Generation Oncology Devices Product Portfolios and Specifications
 Table 79. Accuray Next-Generation Oncology Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. Accuray Main Business
 Table 81. Accuray Latest Developments
 Table 82. IBA Basic Information, Next-Generation Oncology Devices Manufacturing Base, Sales Area and Its Competitors
 Table 83. IBA Next-Generation Oncology Devices Product Portfolios and Specifications
 Table 84. IBA Next-Generation Oncology Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 85. IBA Main Business
 Table 86. IBA Latest Developments
 Table 87. Philips Basic Information, Next-Generation Oncology Devices Manufacturing Base, Sales Area and Its Competitors
 Table 88. Philips Next-Generation Oncology Devices Product Portfolios and Specifications
 Table 89. Philips Next-Generation Oncology Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Philips Main Business
 Table 91. Philips Latest Developments
 Table 92. GE Basic Information, Next-Generation Oncology Devices Manufacturing Base, Sales Area and Its Competitors
 Table 93. GE Next-Generation Oncology Devices Product Portfolios and Specifications
 Table 94. GE Next-Generation Oncology Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 95. GE Main Business
 Table 96. GE Latest Developments


List of Figures
 Figure 1. Picture of Next-Generation Oncology Devices
 Figure 2. Next-Generation Oncology Devices Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Next-Generation Oncology Devices Sales Growth Rate 2020-2031 (K Units)
 Figure 7. Global Next-Generation Oncology Devices Revenue Growth Rate 2020-2031 ($ millions)
 Figure 8. Next-Generation Oncology Devices Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 9. Next-Generation Oncology Devices Sales Market Share by Country/Region (2024)
 Figure 10. Next-Generation Oncology Devices Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 11. Product Picture of Radiation Therapy Equipment
 Figure 12. Product Picture of Endoscopic Equipment
 Figure 13. Global Next-Generation Oncology Devices Sales Market Share by Type in 2025
 Figure 14. Global Next-Generation Oncology Devices Revenue Market Share by Type (2020-2025)
 Figure 15. Next-Generation Oncology Devices Consumed in Breast Cancer
 Figure 16. Global Next-Generation Oncology Devices Market: Breast Cancer (2020-2025) & (K Units)
 Figure 17. Next-Generation Oncology Devices Consumed in Lung Cancer
 Figure 18. Global Next-Generation Oncology Devices Market: Lung Cancer (2020-2025) & (K Units)
 Figure 19. Next-Generation Oncology Devices Consumed in Oral Cancer
 Figure 20. Global Next-Generation Oncology Devices Market: Oral Cancer (2020-2025) & (K Units)
 Figure 21. Next-Generation Oncology Devices Consumed in Stomach Cancer
 Figure 22. Global Next-Generation Oncology Devices Market: Stomach Cancer (2020-2025) & (K Units)
 Figure 23. Next-Generation Oncology Devices Consumed in Cervical Cancer
 Figure 24. Global Next-Generation Oncology Devices Market: Cervical Cancer (2020-2025) & (K Units)
 Figure 25. Global Next-Generation Oncology Devices Sale Market Share by Application (2024)
 Figure 26. Global Next-Generation Oncology Devices Revenue Market Share by Application in 2025
 Figure 27. Next-Generation Oncology Devices Sales by Company in 2025 (K Units)
 Figure 28. Global Next-Generation Oncology Devices Sales Market Share by Company in 2025
 Figure 29. Next-Generation Oncology Devices Revenue by Company in 2025 ($ millions)
 Figure 30. Global Next-Generation Oncology Devices Revenue Market Share by Company in 2025
 Figure 31. Global Next-Generation Oncology Devices Sales Market Share by Geographic Region (2020-2025)
 Figure 32. Global Next-Generation Oncology Devices Revenue Market Share by Geographic Region in 2025
 Figure 33. Americas Next-Generation Oncology Devices Sales 2020-2025 (K Units)
 Figure 34. Americas Next-Generation Oncology Devices Revenue 2020-2025 ($ millions)
 Figure 35. APAC Next-Generation Oncology Devices Sales 2020-2025 (K Units)
 Figure 36. APAC Next-Generation Oncology Devices Revenue 2020-2025 ($ millions)
 Figure 37. Europe Next-Generation Oncology Devices Sales 2020-2025 (K Units)
 Figure 38. Europe Next-Generation Oncology Devices Revenue 2020-2025 ($ millions)
 Figure 39. Middle East & Africa Next-Generation Oncology Devices Sales 2020-2025 (K Units)
 Figure 40. Middle East & Africa Next-Generation Oncology Devices Revenue 2020-2025 ($ millions)
 Figure 41. Americas Next-Generation Oncology Devices Sales Market Share by Country in 2025
 Figure 42. Americas Next-Generation Oncology Devices Revenue Market Share by Country (2020-2025)
 Figure 43. Americas Next-Generation Oncology Devices Sales Market Share by Type (2020-2025)
 Figure 44. Americas Next-Generation Oncology Devices Sales Market Share by Application (2020-2025)
 Figure 45. United States Next-Generation Oncology Devices Revenue Growth 2020-2025 ($ millions)
 Figure 46. Canada Next-Generation Oncology Devices Revenue Growth 2020-2025 ($ millions)
 Figure 47. Mexico Next-Generation Oncology Devices Revenue Growth 2020-2025 ($ millions)
 Figure 48. Brazil Next-Generation Oncology Devices Revenue Growth 2020-2025 ($ millions)
 Figure 49. APAC Next-Generation Oncology Devices Sales Market Share by Region in 2025
 Figure 50. APAC Next-Generation Oncology Devices Revenue Market Share by Region (2020-2025)
 Figure 51. APAC Next-Generation Oncology Devices Sales Market Share by Type (2020-2025)
 Figure 52. APAC Next-Generation Oncology Devices Sales Market Share by Application (2020-2025)
 Figure 53. China Next-Generation Oncology Devices Revenue Growth 2020-2025 ($ millions)
 Figure 54. Japan Next-Generation Oncology Devices Revenue Growth 2020-2025 ($ millions)
 Figure 55. South Korea Next-Generation Oncology Devices Revenue Growth 2020-2025 ($ millions)
 Figure 56. Southeast Asia Next-Generation Oncology Devices Revenue Growth 2020-2025 ($ millions)
 Figure 57. India Next-Generation Oncology Devices Revenue Growth 2020-2025 ($ millions)
 Figure 58. Australia Next-Generation Oncology Devices Revenue Growth 2020-2025 ($ millions)
 Figure 59. China Taiwan Next-Generation Oncology Devices Revenue Growth 2020-2025 ($ millions)
 Figure 60. Europe Next-Generation Oncology Devices Sales Market Share by Country in 2025
 Figure 61. Europe Next-Generation Oncology Devices Revenue Market Share by Country (2020-2025)
 Figure 62. Europe Next-Generation Oncology Devices Sales Market Share by Type (2020-2025)
 Figure 63. Europe Next-Generation Oncology Devices Sales Market Share by Application (2020-2025)
 Figure 64. Germany Next-Generation Oncology Devices Revenue Growth 2020-2025 ($ millions)
 Figure 65. France Next-Generation Oncology Devices Revenue Growth 2020-2025 ($ millions)
 Figure 66. UK Next-Generation Oncology Devices Revenue Growth 2020-2025 ($ millions)
 Figure 67. Italy Next-Generation Oncology Devices Revenue Growth 2020-2025 ($ millions)
 Figure 68. Russia Next-Generation Oncology Devices Revenue Growth 2020-2025 ($ millions)
 Figure 69. Middle East & Africa Next-Generation Oncology Devices Sales Market Share by Country (2020-2025)
 Figure 70. Middle East & Africa Next-Generation Oncology Devices Sales Market Share by Type (2020-2025)
 Figure 71. Middle East & Africa Next-Generation Oncology Devices Sales Market Share by Application (2020-2025)
 Figure 72. Egypt Next-Generation Oncology Devices Revenue Growth 2020-2025 ($ millions)
 Figure 73. South Africa Next-Generation Oncology Devices Revenue Growth 2020-2025 ($ millions)
 Figure 74. Israel Next-Generation Oncology Devices Revenue Growth 2020-2025 ($ millions)
 Figure 75. Turkey Next-Generation Oncology Devices Revenue Growth 2020-2025 ($ millions)
 Figure 76. GCC Countries Next-Generation Oncology Devices Revenue Growth 2020-2025 ($ millions)
 Figure 77. Manufacturing Cost Structure Analysis of Next-Generation Oncology Devices in 2025
 Figure 78. Manufacturing Process Analysis of Next-Generation Oncology Devices
 Figure 79. Industry Chain Structure of Next-Generation Oncology Devices
 Figure 80. Channels of Distribution
 Figure 81. Global Next-Generation Oncology Devices Sales Market Forecast by Region (2026-2031)
 Figure 82. Global Next-Generation Oncology Devices Revenue Market Share Forecast by Region (2026-2031)
 Figure 83. Global Next-Generation Oncology Devices Sales Market Share Forecast by Type (2026-2031)
 Figure 84. Global Next-Generation Oncology Devices Revenue Market Share Forecast by Type (2026-2031)
 Figure 85. Global Next-Generation Oncology Devices Sales Market Share Forecast by Application (2026-2031)
 Figure 86. Global Next-Generation Oncology Devices Revenue Market Share Forecast by Application (2026-2031)

Companies Mentioned

Elekta

Accuray

IBA

Philips

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff